Status:
RECRUITING
ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO)
Lead Sponsor:
IHF GmbH - Institut für Herzinfarktforschung
Collaborating Sponsors:
Abbott
Conditions:
Myocardial Ischemia
Eligibility:
All Genders
18+ years
Brief Summary
The study aims to assess contemporary practice in OCT use during routine interven-tional practice and to assess the impact of the MLD-MAX algorithm on real-world PCI in a large unselected European all...
Detailed Description
Angiography is the current standard method to guide PCI strategy in clinical practice. However, angiography has a number of well-described limitations, primarily through only providing an assessment o...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Patients with evidence of myocardial ischemia (e.g. stable angi-na, silent ischemia, unstable angina, or acute myocardial infarc-tion) undergoing OCT-guided lesion evaluation (OCT-scan using the devices must be performed either to guide PCI (following the MLD-MAX-algorithm) or to investigate a coronary lesion for fur-ther clinical treatment)
- Written informed consent (defined as legally effective, docu-mented confirmation of a subject's (or their legally authorized representative or guardian) voluntary agreement to participate in a particular clinical study) to participate in this clinical inves-tigation
Exclusion
- none
Key Trial Info
Start Date :
May 4 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 30 2026
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05324683
Start Date
May 4 2023
End Date
January 30 2026
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum Frankfurt - Med. Klinik 3 - Kardiologie
Frankfurt am Main, Germany, 60590